{
    "2018-06-28": [
        [
            {
                "time": "",
                "original_text": "华大基因通过ISO 13485升标评审",
                "features": {
                    "keywords": [
                        "华大基因",
                        "ISO 13485",
                        "升标评审"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华大基因加入“一带一路包虫病和人兽共患绦囊虫病消除和控制网络”理事会",
                "features": {
                    "keywords": [
                        "华大基因",
                        "一带一路",
                        "包虫病",
                        "人兽共患绦囊虫病",
                        "消除和控制网络"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "国际合作"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华大基因回应举报后连续两日暴跌 成交金额超1亿",
                "features": {
                    "keywords": [
                        "华大基因",
                        "举报",
                        "暴跌",
                        "成交金额"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因跌破百元关口 较去年高位缩水超六成",
                "features": {
                    "keywords": [
                        "华大基因",
                        "跌破",
                        "百元关口",
                        "缩水",
                        "六成"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因被举报“假高科技” 股价下跌超8%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "举报",
                        "假高科技",
                        "股价下跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因4年几乎无新研究专利 研发费不及销售费用一半",
                "features": {
                    "keywords": [
                        "华大基因",
                        "研究专利",
                        "研发费",
                        "销售费用"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}